Ventricular assist device in severe heart failure - Effects on cytokines, complement and body weight

被引:46
作者
Clark, AL
Leobe, M
Potapov, EV
Egerer, K
Knosalla, C
Hetzer, R
Anker, SD
机构
[1] Castle Hill Hosp, Dept Acad Cardiol, Kingston Upon Hull HU16 5JQ, N Humberside, England
[2] Deutsch Herzzentrum Berlin, Dept Thorac & Cardiovasc Surg, Berlin, Germany
[3] MDC Berlin, Franz Volhard Klin, Charite, Berlin, Germany
[4] Natl Heart & Lung Inst, Dept Cardiac Med, London SW3 6LY, England
关键词
chronic heart failure; ventricular assist device; cytokines; tumour necrosis factor alpha;
D O I
10.1053/euhj.2001.2693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Inflammatory and immune activation and body wasting are important features of end-stage chronic heart failure. It is not known whether restoration of cardiac output by assist device implantation can improve these abnormalities. Methods We studied 48 patients (39 males; age 45 +/-2 years) with NYHA class IV heart failure. All patients underwent ventricular assist device implantation for endstage heart failure as a bridge to cardiac transplantation. Plasma levels Of tumour necrosis factor alpha, and its receptors, interleukin-6, elastase, activated complement, and soluble CD14 receptors were measured at the time of operation and in survivors at I week (n=46), 40 days (n=35) and 90 days (n=26). Follow-Lip was for a minimum of I year. Results One-year survival was 35% (95% Cl: 22-49%). Body mass index was the only predictor of survival (body mass index > 25 (n=16); survival 63 (39-86)%; body mass index < 25 (n=32), survival 22 (7.5-36)%: P=0.003). Tumour necrosis factor alpha fell from 9.66 +/-1.33 pg.ml(-1) to 4.2 +/-1.0 at I week (P=0.008), but returned to preoperative levels at 90 days. Interleukin-6, activated complement and elastase fell progressively to 40 days, but were rising at 90 days. There was no change in tumour necrosis factor receptor. There was a gradual rise in CD14 (3.99 +/-0.15 mug.ml(-1) at baseline, 5.02 +/-0.39 at 90 days, P=0.006). After surgery, body weight fell from 80 +/-2 to 73 +/-2 kg by I month (P <0.001) and to 72 +/-2 kg at 90 days. Conclusions Ventricular assist device implantation results in a short-term fall in tumour necrosis factor alpha and interleukin-6, but no change in CD14 or tumour necrosis factor receptor, suggesting that the pathophysiological process resulting in inflammation was not altered by left ventricular assist device implantation. Low body mass index is related to poor outcome after assist device implantation, and no weight gain. (C) 2001 The European Society of Cardiology.
引用
收藏
页码:2275 / 2283
页数:9
相关论文
共 35 条
  • [21] Uric acid in chronic heart failure: A marker of chronic inflammation
    Leyva, F
    Anker, SD
    Godsland, IF
    Teixeira, M
    Hellewell, PG
    Kox, WJ
    Poole-Wilson, PA
    Coats, AJS
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 (12) : 1814 - 1822
  • [22] Complement activation in patients undergoing mechanical circulatory support
    Loebe, M
    Gorman, K
    Burger, R
    Gage, JE
    Harke, C
    Hetzer, R
    [J]. ASAIO JOURNAL, 1998, 44 (05) : M340 - M346
  • [23] Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement
    Loebe, M
    Hennig, E
    Muller, J
    Spiegelsberger, S
    Weng, Y
    Hetzer, R
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 : S18 - S24
  • [24] Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?
    Massad, MG
    McCarthy, PM
    Smedira, NG
    Cook, DJ
    Ratliff, NB
    Goormastic, M
    Vargo, RL
    Navia, J
    Young, JB
    Stewart, RW
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (05) : 1275 - 1281
  • [25] MCCARTHY PM, 1991, J THORAC CARDIOV SUR, V102, P578
  • [26] Endotoxin and immune activation in chronic heart failure: a prospective cohort study
    Niebauer, J
    Volk, HD
    Kemp, M
    Dominguez, M
    Schumann, RR
    Rauchhaus, M
    Poole-Wilson, PA
    Coats, AJS
    Anker, SD
    [J]. LANCET, 1999, 353 (9167) : 1838 - 1842
  • [27] Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation
    Niebauer, J
    Pflaum, CD
    Clark, AL
    Strasburger, CJ
    Hooper, J
    Poole-Wilson, PA
    Coats, AJS
    Anker, SD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (02) : 393 - 397
  • [28] Rose EA, 1994, CIRCULATION, V90, P1187
  • [29] FREE-RADICALS AND PHAGOCYTIC-CELLS
    ROSEN, GM
    POU, S
    RAMOS, CL
    COHEN, MS
    BRITIGAN, BE
    [J]. FASEB JOURNAL, 1995, 9 (02) : 200 - 209